During the past decade, Landesklinikum Korneuburg-Stockerau, Standort Stockerau conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Landesklinikum Korneuburg-Stockerau, Standort Stockerau" are "Diabetes Mellitus, Type 2" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Landesklinikum Korneuburg-Stockerau, Standort Stockerau" in a lesser frequency.

Most popular intervention types in "Landesklinikum Korneuburg-Stockerau, Standort Stockerau" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Insulin Degludec" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landesklinikum Korneuburg-Stockerau, Standort Stockerau" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Landesklinikum Korneuburg-Stockerau, Standort Stockerau". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Landesklinikum Korneuburg-Stockerau, Standort Stockerau, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Landesklinikum Korneuburg-Stockerau, Standort Stockerau, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".